Sagasrin-GSM
Description_Effects
Sagasrin-GSM is a combination medicine containing Glucosamine Sulphate Potassium (750 mg), Methyl Sulfonyl Methane – MSM (250 mg), and Diacerein (50 mg). It is primarily used for the treatment and long-term management of osteoarthritis and other degenerative joint disorders. This formulation helps in reducing joint pain, improving mobility, and slowing cartilage degradation. Glucosamine is a naturally occurring substance found in joint cartilage. In supplement form as Glucosamine Sulphate Potassium, it helps stimulate the formation of cartilage and synovial fluid, which cushions and lubricates joints. It plays a key role in rebuilding damaged cartilage and maintaining joint flexibility. Methyl Sulfonyl Methane (MSM) is an organic sulfur compound known for its anti-inflammatory and antioxidant properties. It reduces joint pain and stiffness by lowering inflammation, and it supports collagen production, which is essential for joint and connective tissue health. Diacerein is a slow-acting anti-inflammatory drug that works by inhibiting interleukin-1 (IL-1), a key molecule involved in cartilage degradation. It helps reduce inflammation and pain, while also providing disease-modifying effects in osteoarthritis. Sagasrin-GSM offers a comprehensive approach to joint care by combining symptomatic relief with cartilage repair and protection, making it effective for long-term joint health. Regular use under medical supervision may improve quality of life in patients with joint degeneration.
